Matches in Nanopublications for { ?s ?p "[VEGFR1, TGFBR1, PDGFRA, SSTR5, SSTR2A, and IGF1R exhibited the highest levels of expression in the largest percentages of PETs.Anticancer drugs BMS-754807 (selective for IGF1R/IR), 17-(allylamino)-17-demethoxygeldanamycin (17-AAG, targeting Hsp90), and axitinib (directed toward VEGFR1-3/PDGFRA-B/KIT) induced growth inhibition of human QGP-1 PET cells with IC50 values (nM) of 273, 723, and 743, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP616469.RAByzTiXAqFlJdt9AIyUeckgBaqkmLx9K6_FWGFteBYKM130_assertion description "[VEGFR1, TGFBR1, PDGFRA, SSTR5, SSTR2A, and IGF1R exhibited the highest levels of expression in the largest percentages of PETs.Anticancer drugs BMS-754807 (selective for IGF1R/IR), 17-(allylamino)-17-demethoxygeldanamycin (17-AAG, targeting Hsp90), and axitinib (directed toward VEGFR1-3/PDGFRA-B/KIT) induced growth inhibition of human QGP-1 PET cells with IC50 values (nM) of 273, 723, and 743, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP616469.RAByzTiXAqFlJdt9AIyUeckgBaqkmLx9K6_FWGFteBYKM130_provenance.
- NP679944.RAh169k41-6YDh7FWF4RpHQVl4zz1CpOIukSbshkbFZoc130_assertion description "[VEGFR1, TGFBR1, PDGFRA, SSTR5, SSTR2A, and IGF1R exhibited the highest levels of expression in the largest percentages of PETs.Anticancer drugs BMS-754807 (selective for IGF1R/IR), 17-(allylamino)-17-demethoxygeldanamycin (17-AAG, targeting Hsp90), and axitinib (directed toward VEGFR1-3/PDGFRA-B/KIT) induced growth inhibition of human QGP-1 PET cells with IC50 values (nM) of 273, 723, and 743, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP679944.RAh169k41-6YDh7FWF4RpHQVl4zz1CpOIukSbshkbFZoc130_provenance.
- NP847851.RAnJbhqNVB2ehCTrM-hdoVOXFP2kjM5HAhJPbEsp8KhDM130_assertion description "[VEGFR1, TGFBR1, PDGFRA, SSTR5, SSTR2A, and IGF1R exhibited the highest levels of expression in the largest percentages of PETs.Anticancer drugs BMS-754807 (selective for IGF1R/IR), 17-(allylamino)-17-demethoxygeldanamycin (17-AAG, targeting Hsp90), and axitinib (directed toward VEGFR1-3/PDGFRA-B/KIT) induced growth inhibition of human QGP-1 PET cells with IC50 values (nM) of 273, 723, and 743, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP847851.RAnJbhqNVB2ehCTrM-hdoVOXFP2kjM5HAhJPbEsp8KhDM130_provenance.
- NP568793.RASouo1Fh_xiRITdyXAFdWspcegCW-Zx54JVHP-y6eLUw130_assertion description "[VEGFR1, TGFBR1, PDGFRA, SSTR5, SSTR2A, and IGF1R exhibited the highest levels of expression in the largest percentages of PETs.Anticancer drugs BMS-754807 (selective for IGF1R/IR), 17-(allylamino)-17-demethoxygeldanamycin (17-AAG, targeting Hsp90), and axitinib (directed toward VEGFR1-3/PDGFRA-B/KIT) induced growth inhibition of human QGP-1 PET cells with IC50 values (nM) of 273, 723, and 743, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP568793.RASouo1Fh_xiRITdyXAFdWspcegCW-Zx54JVHP-y6eLUw130_provenance.
- NP321481.RA31LdbzGKY-w6A1qYNwXSAsTq4pkkBA2QosdMFRtQRH0130_assertion description "[VEGFR1, TGFBR1, PDGFRA, SSTR5, SSTR2A, and IGF1R exhibited the highest levels of expression in the largest percentages of PETs.Anticancer drugs BMS-754807 (selective for IGF1R/IR), 17-(allylamino)-17-demethoxygeldanamycin (17-AAG, targeting Hsp90), and axitinib (directed toward VEGFR1-3/PDGFRA-B/KIT) induced growth inhibition of human QGP-1 PET cells with IC50 values (nM) of 273, 723, and 743, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP321481.RA31LdbzGKY-w6A1qYNwXSAsTq4pkkBA2QosdMFRtQRH0130_provenance.
- NP917498.RAIDfrQcKOJIRqtbH27eX68x9slIwAoHHekhYGjxQUGcQ130_assertion description "[VEGFR1, TGFBR1, PDGFRA, SSTR5, SSTR2A, and IGF1R exhibited the highest levels of expression in the largest percentages of PETs.Anticancer drugs BMS-754807 (selective for IGF1R/IR), 17-(allylamino)-17-demethoxygeldanamycin (17-AAG, targeting Hsp90), and axitinib (directed toward VEGFR1-3/PDGFRA-B/KIT) induced growth inhibition of human QGP-1 PET cells with IC50 values (nM) of 273, 723, and 743, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP917498.RAIDfrQcKOJIRqtbH27eX68x9slIwAoHHekhYGjxQUGcQ130_provenance.